Global COVID-19 IgM/IgG Rapid Test Kits Market Size, Competition Landscape and Supply Chain Research Report 2025

Research Summary

COVID-19 IgM/IgG rapid test kits are medical diagnostic tools designed to detect the presence of both immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies specific to the SARS-CoV-2 virus, which causes COVID-19. These kits typically use a small blood sample, obtained through a finger prick or venous draw, and provide results within a short time frame, often within 15 to 20 minutes. IgM antibodies are typically produced by the body in the early stages of infection, while IgG antibodies develop later and can indicate a past infection or potential immunity. The presence of both IgM and IgG antibodies in a person＇s blood can help healthcare professionals assess the stage of infection, identify recent or past exposure to the virus, and provide insights into potential immunity. However, it＇s important to note that these rapid test kits may have varying degrees of accuracy and sensitivity, and they should not be solely relied upon for definitive diagnoses. Confirmatory testing through molecular methods like PCR is necessary to confirm active infections. COVID-19 IgM/IgG rapid test kits play a valuable role in serological studies, surveillance, and screening efforts to understand the spread and impact of the disease in populations.

According to WENKH research statistics, the global COVID-19 IgM/IgG Rapid Test Kits market sales revenue reached  Million USD in 2024 and is expected to reach  Million USD by 2032, with a compound annual growth rate (CAGR) of  % from 2025 to 2032. Among them, the Asia-Pacific COVID-19 IgM/IgG Rapid Test Kits market has experienced rapid changes in recent years, reaching  Million USD in 2024, accounting for approximately  % of the global market share. It is projected to reach  Million USD by 2032.

The global COVID-19 IgM/IgG Rapid Test Kits market is highly competitive, with key market players including Cellex, RayBiotech, Biopanda, BioMedomics, GenBody, SD Biosensor, Advaite, Premier Biotech, Epitope Diagnostics, CTK Biotech, Creative Diagnostics, Eagle Biosciences, Sure Biotech, Sugentech, Sensing self, Euroimmun AG, PharmACT, Liming Bio, Livzon Diagnostics, Beijing Wantai, Shenzhen BioEasy Biotechnology, Orient Gene Biotech, INNOVITA, Dynamiker, Guangzhou Wonfo Bio-Tech, etc. This report categorizes the competitive landscape of the global COVID-19 IgM/IgG Rapid Test Kits market into three tiers based on annual revenue, with the top three market players holding approximately  % of the total market share.

This report provides an in-depth analysis of the global COVID-19 IgM/IgG Rapid Test Kits market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, revenue, sales volume and gross profit margin of major manufacturers in the global COVID-19 IgM/IgG Rapid Test Kits industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different segments of COVID-19 IgM/IgG Rapid Test Kits and their downstream application fields.

In terms of data coverage, this report includes extensive time-series data. Historical data spans from 2020 to 2024, providing a solid foundation for analyzing market development trends. The year 2025 is used as a base year to accurately assess the current market landscape, while forecast data extends from 2026 to 2032, using scientific analysis methods and models to offer forward-looking projections and insights into the market's future trajectory. This provides valuable reference information for industry participants and stakeholders.

The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the revenue and sales volume of COVID-19 IgM/IgG Rapid Test Kits in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the COVID-19 IgM/IgG Rapid Test Kits market. By considering local policies, this report evaluates the market prospects of COVID-19 IgM/IgG Rapid Test Kits in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.

This report places significant emphasis on data quality and reliability, leveraging a wide range of data sources to ensure accuracy and validity. Primary data collection is conducted through multiple channels, including in-depth interviews with senior corporate executives, industry experts, supply chain participants, and end consumers. This helps to gain insights into corporate strategic planning, industry policies, supply chain dynamics, and user experiences. Secondary data sources cover an extensive range, including authoritative government statistics, customs databases, industry related reports, third-party paid databases, investment research reports, academic studies, corporate financial statements, real-time media updates, and information from international organizations, all of which serve as a solid foundation for data verification and analysis.

Companies Covered

Cellex

RayBiotech

Biopanda

BioMedomics

GenBody

SD Biosensor

Advaite

Premier Biotech

Epitope Diagnostics

CTK Biotech

Creative Diagnostics

Eagle Biosciences

Sure Biotech

Sugentech

Sensing self

Euroimmun AG

PharmACT

Liming Bio

Livzon Diagnostics

Beijing Wantai

Shenzhen BioEasy Biotechnology

Orient Gene Biotech

INNOVITA

Dynamiker

Guangzhou Wonfo Bio-Tech

Product Segment

RDT(Rapid Diagnostic Test)

ELISA(Enzyme-linked Immunosorbent Aassay)

Neutralization Assay

Product Application

Hospital

Special Clinic

Research Institutions

Chapter Scope

Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects

Chapter 2: Global COVID-19 IgM/IgG Rapid Test Kits Industry Chain Analysis

Chapter 3: Global COVID-19 IgM/IgG Rapid Test Kits Industry Environment Analysis and Porter's Five Forces Analysis

Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global COVID-19 IgM/IgG Rapid Test Kits Market (Market Share, Product Revenue and Sales Volume Comparison, Tier Division, Corporate Expansion and M&A Trends)

Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Sales Volume, Product Average Price, Product Gross Profit Margin and Geographical Sales Share)

Chapter 6: Global COVID-19 IgM/IgG Rapid Test Kits Product Segment, Downstream Application and Major Regional Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 7: North America COVID-19 IgM/IgG Rapid Test Kits Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 8: Europe COVID-19 IgM/IgG Rapid Test Kits Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 9: China COVID-19 IgM/IgG Rapid Test Kits Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 10: Asia Pacific (excluding China) COVID-19 IgM/IgG Rapid Test Kits Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 11: Latin America COVID-19 IgM/IgG Rapid Test Kits Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 12: Middle East and Africa COVID-19 IgM/IgG Rapid Test Kits Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 13: Research Conclusion

Chapter 14: Methodology and Data Source

Purpose and Value of the Report

Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.

Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.

Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.

Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.

Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.

Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.